CJ Cheiljedang is targetting sales of 200 billion won in plant-based foods by 2025, setting it as the company’s new growth engine. The South Korean food conglomerate's main target is overseas markets where it aims to generate 70 percent of its sales.
Jung Hyun-hak, the head of CJ’s plant-based food business, noted that the three trends of health and wellness, sustainability, and animal welfare merge that is making plant-based food a global megatrend.
He added that they expect the global plant-based food market to grow up to 35 trillion won in the next 10 years.
According to CJ, the 2.64 trillion won the global market for plant-based food is expanding by double digits annually. This year's domestic market is estimated to be worth 14.1 billion won, an increase of 104.3 percent from 2018.
CJ debuted vegan dumplings and kimchi under its independent plant-based cuisine brand PlanTable last December to tap into the expanding vegan market both inside and outside of South Korea.
Textured Vegetable Protein (TVP), a plant-based protein substitute created by the company utilizing soy and peas, was introduced this month by CJ along with meatless "tteokgalbi," grilled short rib patties, and other protein products.
Since its inception six months ago, PlanTable products have been offered in 20 different nations, including the US, Japan, and Australia.
The food manufacturer has added a different production line to its No. 2 factory in Incheon, roughly 30 kilometers west of Seoul, as well as increased its production capacity. According to CJ, the new line can produce 1,000 tons annually.
For its expanding international companies, it said it is taking into consideration a plan to construct a second vegan production facility.
Due to the significant vegan population and the developed markets for plant-based substitutes, the US and European markets are its primary targets, according to Jung.


Fertile land for growing vegetables is at risk — but a scientific discovery could turn the tide
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
How America courted increasingly destructive wildfires − and what that means for protecting homes today
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
An unexpected anomaly was found in the Pacific Ocean – and it could be a global time marker
France's 2025 Budget Deficit Shrinks More Than Expected, Easing Fiscal Pressure
Fungi are among the planet’s most important organisms — yet they continue to be overlooked in conservation strategies
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Dollar Strengthens as U.S.-Iran Peace Talks Send Mixed Signals
Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism 



